Medicines in Mexico, 1990-2004: systematic review of research on access and use
- PMID: 19082258
- DOI: 10.1590/s0036-36342008001000008
Medicines in Mexico, 1990-2004: systematic review of research on access and use
Abstract
Objective: To review original research studies published between 1990 and 2004 on the access and use of medicines in Mexico to assess the knowledge base for reforming Mexico's pharmaceutical policy.
Material and methods: A literature review using electronic databases was conducted of original studies published in the last 15 years about access and use of medicines in Mexico. In addition, a manual search of six relevant journals was performed. Excluded were publications on herbal, complementary and alternative medicines.
Results: Were identified 108 original articles as being relevant, out of 2289 titles reviewed, highlighting four policy-related problems: irrational prescribing, harmful self-medication, inequitable access, and frequent drug stock shortage in public health centers.
Conclusions: This review identified two priorities for Mexico's pharmaceutical policy and strategies: tackling the irrational use of medicines and the inadequate access of medicines. These are critical priorities for a new national pharmaceutical policy.
Similar articles
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4. Cochrane Database Syst Rev. 2017. PMID: 28178770 Free PMC article.
-
Financial arrangements for health systems in low-income countries: an overview of systematic reviews.Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD011084. doi: 10.1002/14651858.CD011084.pub2. Cochrane Database Syst Rev. 2017. PMID: 28891235 Free PMC article.
-
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590. Health Technol Assess. 2021. PMID: 34668482
-
Pharmaceutical policies: effects of regulating drug insurance schemes.Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2. Cochrane Database Syst Rev. 2022. PMID: 35502614 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
Cited by
-
Prevalence and characterization of undiagnosed arterial hypertension in the eastern zone of Mexico.J Clin Hypertens (Greenwich). 2022 Feb;24(2):131-139. doi: 10.1111/jch.14414. Epub 2021 Dec 28. J Clin Hypertens (Greenwich). 2022. PMID: 34962058 Free PMC article.
-
Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.Global Health. 2017 Aug 1;13(1):53. doi: 10.1186/s12992-017-0281-1. Global Health. 2017. PMID: 28764738 Free PMC article.
-
Supporting the Medication Adherence of Older Mexican Adults Through External Cues Provided With Ambient Displays: Feasibility Randomized Controlled Trial.JMIR Mhealth Uhealth. 2020 Mar 2;8(3):e14680. doi: 10.2196/14680. JMIR Mhealth Uhealth. 2020. PMID: 32130164 Free PMC article. Clinical Trial.
-
The fuzzy line between needs, coverage, and excess in the Mexican Formulary List: an example of qualitative market width analysis.Eur J Clin Pharmacol. 2013 Apr;69(4):949-56. doi: 10.1007/s00228-012-1421-4. Epub 2012 Oct 23. Eur J Clin Pharmacol. 2013. PMID: 23090699
-
User Perceptions of an mHealth Medicine Dosing Tool for Community Health Workers.JMIR Mhealth Uhealth. 2013 Apr 4;1(1):e2. doi: 10.2196/mhealth.2459. JMIR Mhealth Uhealth. 2013. PMID: 25100670 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical